Click on image to view larger version.

Figure 5 Threshold Risk of VLST in DES as a Function of the Baseline BMS Population Risk of Restenosis

Under the base case assumptions of annual BMS TVR rate of 14%, the incremental risk of VLST in DES over 3 years was 0.14%/year, over which the preferred strategy would be BMS. As the population risk of restenosis (and TVR) increases over the expected rate of 14%, as observed in diabetic patients, small vessels, and long lesions, the annual incremental risk of VLST in DES over BMS that preserves DES benefit increased. Abbreviations as in Figures 1 and 2.